MXPA03004818A - Composicion conteniendo estatinas y calcio para salud cardiovascular mejorada. - Google Patents
Composicion conteniendo estatinas y calcio para salud cardiovascular mejorada.Info
- Publication number
- MXPA03004818A MXPA03004818A MXPA03004818A MXPA03004818A MXPA03004818A MX PA03004818 A MXPA03004818 A MX PA03004818A MX PA03004818 A MXPA03004818 A MX PA03004818A MX PA03004818 A MXPA03004818 A MX PA03004818A MX PA03004818 A MXPA03004818 A MX PA03004818A
- Authority
- MX
- Mexico
- Prior art keywords
- calcium
- composition containing
- cardiovascular health
- improved cardiovascular
- containing statins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25389900P | 2000-11-29 | 2000-11-29 | |
| PCT/US2001/044734 WO2002043659A2 (en) | 2000-11-29 | 2001-11-29 | Composition containing statins and calcium for improved cardiovascular health |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03004818A true MXPA03004818A (es) | 2003-09-10 |
Family
ID=22962156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03004818A MXPA03004818A (es) | 2000-11-29 | 2001-11-29 | Composicion conteniendo estatinas y calcio para salud cardiovascular mejorada. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1339429A4 (ja) |
| JP (1) | JP2004514684A (ja) |
| AU (1) | AU3651102A (ja) |
| CA (1) | CA2427618A1 (ja) |
| MX (1) | MXPA03004818A (ja) |
| WO (1) | WO2002043659A2 (ja) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4611622B2 (ja) * | 2002-07-11 | 2011-01-12 | 第一三共株式会社 | 血中脂質改善又は血中ホモシステイン低下のための医薬組成物 |
| CA2492781A1 (en) * | 2002-07-11 | 2004-01-22 | Sankyo Company Limited | Medicinal composition for mitigating blood lipid or lowering blood homocystein |
| EP2384750A1 (en) * | 2002-09-27 | 2011-11-09 | Martek Biosciences Corporation | Improved Glycemic Control for Prediabetes and/or Diabetes Type II using Docohexaenoic Acid |
| EP1551382A4 (en) * | 2002-09-27 | 2007-01-24 | Martek Biosciences Corp | PROPHYLACTIC TREATMENT WITH DOCOSAHEXAENIC ACID FOR PATIENTS WITH SUBCLINIC INFLAMMATION |
| FR2847472B1 (fr) * | 2002-11-22 | 2006-08-11 | Synergia | Nouvelles compositions pharmaceutiques notamment pour la prevention des pathologies cardio-vasculaires |
| DE10261067A1 (de) * | 2002-12-24 | 2004-08-05 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure |
| AU2004305154A1 (en) * | 2003-12-23 | 2005-07-07 | Medicure International Inc. | Combination therapies employing a composition comprising a HMG CoA reductase inhibitor and a vitamin B6 related compound |
| ITRM20040395A1 (it) * | 2004-08-03 | 2004-11-03 | Sigma Tau Ind Farmaceuti | Composizione comprendente statine e acidi grassi omega 3. |
| BRPI0514189A (pt) * | 2004-08-06 | 2008-06-03 | Transform Pharmaceuticals Inc | composições farmacêuticas de estatina e métodos de tratamento relacionados |
| US20070259022A1 (en) * | 2004-08-23 | 2007-11-08 | Molhuizen Henricus O F | Composition Comprising Statin |
| ES2255426B1 (es) * | 2004-10-19 | 2007-08-16 | Gp Pharm, S.A. | Formulacion farmaceutica que comprende microcapsulas de estatinas suspendidas en ester alquilicos de acidos grasos poliinsaturados (pufa). |
| JP2008522970A (ja) * | 2004-12-06 | 2008-07-03 | レリアント ファーマスーティカルズ インコーポレイテッド | 脂質療法用のオメガ−３脂肪酸類及び異常脂質血症薬剤 |
| US20060135610A1 (en) * | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Cardiovascular compositions |
| MX2008001597A (es) * | 2005-08-04 | 2008-04-04 | Transform Pharmaceuticals Inc | Formulaciones novedosas que comprenden fenofibrato y una estatina y metodos relacionados de tratamiento. |
| WO2007055327A1 (ja) * | 2005-11-11 | 2007-05-18 | Mochida Pharmaceutical Co., Ltd. | ゼリー組成物 |
| WO2007103557A2 (en) * | 2006-03-09 | 2007-09-13 | Reliant Pharmaceuticals, Inc. | Coating capsules with active pharmaceutical ingredients |
| US8784886B2 (en) * | 2006-03-09 | 2014-07-22 | GlaxoSmithKline, LLC | Coating capsules with active pharmaceutical ingredients |
| ITMI20072142A1 (it) * | 2007-11-08 | 2009-05-09 | Yervant Zarmanian | Composizioni farmaceutiche contenenti statine e derivati di acidi grassi omega-3 |
| EP2308493A4 (en) * | 2008-07-07 | 2013-05-01 | Mochida Pharm Co Ltd | ENHANCING OR THERAPEUTIC AGENT FOR DYSLIPIDEMIA |
| GB0818472D0 (en) * | 2008-10-08 | 2008-11-12 | Probio Nutraceuticals As | Composition |
| GB0818473D0 (en) | 2008-10-08 | 2008-11-12 | Probio Nutraceuticals As | Composition |
| ITFI20080243A1 (it) * | 2008-12-15 | 2010-06-16 | Valpharma Sa | Formulazioni per la somministrazione orale di acidi grassi omega polienoici in combinazione con statine di origine naturale o semi-sintetica. |
| EP2488022B1 (en) | 2009-10-16 | 2018-01-10 | Mochida Pharmaceutical Co., Ltd. | Compositions |
| AU2010335077A1 (en) | 2009-12-23 | 2012-06-14 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Combination composition useful for treating cardiovascular diseases |
| WO2012085671A2 (en) * | 2010-12-21 | 2012-06-28 | Omegatri As | Antioxidants in fish oil powder and tablets |
| KR101310710B1 (ko) * | 2011-03-23 | 2013-09-27 | 한미약품 주식회사 | 오메가-3 지방산 에스테르 및 ＨＭＧ-ＣｏＡ 환원효소 억제제를 포함하는 경구용 복합 조성물 |
| FR3007985A1 (fr) * | 2013-07-02 | 2015-01-09 | Internat Nutrition Res Company | Medicament pour la prevention et le traitement des facteurs de risques cardiometaboliques, en particulier maladies cardiovasculaires, pre-diabete, diabete de type ii et steatose hepatique |
| FR3007987A1 (fr) * | 2013-07-02 | 2015-01-09 | Internat Nutrition Res Company | Medicament pour la prevention et le traitement de l'atherosclerose et du survieillissement metabolique |
| FR3007986A1 (fr) * | 2013-07-02 | 2015-01-09 | Internat Nutrition Res Company | Medicament destine a lutter contre l'infertilite et la sous-fertilite en particulier dans le cadre d'une sous fertilite ou infertilite metabolique |
| WO2015000986A1 (fr) * | 2013-07-02 | 2015-01-08 | International Nutrition Research Company | Composition intervenant dans la regulation du dysfonctionnement des cycles de l'energie, de l'inflammation et de l'insulinoresistance et son utilisation notamment dans les maladies cardiometaboliques |
| WO2017180127A1 (en) * | 2016-04-14 | 2017-10-19 | Lucey Michael | Combinational compositions and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4940727A (en) * | 1986-06-23 | 1990-07-10 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
| CA2222278C (en) * | 1995-06-06 | 2008-05-13 | Campbell Soup Company | Mineral supplements for dietetic food |
| EP0904082A4 (en) * | 1996-04-17 | 2001-09-26 | Merck & Co Inc | COMBINATION THERAPY TO REDUCE THE RISKS OF HEART CIRCULAR DISEASES |
| DK0843972T3 (da) * | 1996-11-20 | 2002-12-02 | Nutricia Nv | Næringsmiddelsammensætning, der indeholder fedtstoffer til behandling af stofskiftesygdomme |
-
2001
- 2001-11-29 MX MXPA03004818A patent/MXPA03004818A/es unknown
- 2001-11-29 AU AU3651102A patent/AU3651102A/xx active Pending
- 2001-11-29 JP JP2002545638A patent/JP2004514684A/ja active Pending
- 2001-11-29 WO PCT/US2001/044734 patent/WO2002043659A2/en not_active Application Discontinuation
- 2001-11-29 EP EP01986043A patent/EP1339429A4/en not_active Withdrawn
- 2001-11-29 CA CA002427618A patent/CA2427618A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU3651102A (en) | 2002-06-11 |
| WO2002043659A2 (en) | 2002-06-06 |
| WO2002043659A3 (en) | 2002-09-06 |
| JP2004514684A (ja) | 2004-05-20 |
| EP1339429A2 (en) | 2003-09-03 |
| CA2427618A1 (en) | 2002-06-06 |
| EP1339429A4 (en) | 2007-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03004818A (es) | Composicion conteniendo estatinas y calcio para salud cardiovascular mejorada. | |
| HUP0301745A3 (en) | Cyclopentanoindoles, compositions containing such compounds and their use | |
| MXPA03005275A (es) | Prevencion de la captacion de conservantes en biomateriales. | |
| HUP0400589A3 (en) | Colostrum-based composition | |
| MXPA03003314A (es) | Compuestos de c-nitrosoanilina y sus mezclas como inhibidores de polimerizacion. | |
| SG99895A1 (en) | Proanthocyanidin-containing composition | |
| WO2002000039A3 (en) | PERFUME COMPOSITION | |
| MXPA03009698A (es) | Vacuna multivalente que comprende un antigeno vih y un antigeno vsh y/o un antigeno vph. | |
| HUP0302623A3 (en) | Emulsified food composition | |
| PL350080A1 (en) | Odor−eliminating composition | |
| GB0023891D0 (en) | Composition | |
| GB2368014B (en) | Pharmaceutical composition containing citalopram | |
| GB0109427D0 (en) | Arthropod-controlling composition | |
| MXPA01000464A (es) | Composicion. | |
| AU2001287852A8 (en) | Composition | |
| MXPA03004817A (es) | Composicion dietetica conteniendo acido linoleico conjugado y calcio para salud mejorada. | |
| MXPA03005965A (es) | Composicion farmaceutica que contiene citalopram. | |
| GB0122658D0 (en) | Composting container | |
| GB0007762D0 (en) | Composition | |
| AU2002236511A1 (en) | Composition containing statins and calcium for improved cardiovascular health | |
| GB0025058D0 (en) | Composition | |
| EG23194A (en) | Polymeric composition. | |
| GB0003101D0 (en) | Novel composition | |
| GB0003102D0 (en) | Novel composition | |
| GB0020916D0 (en) | Composition |